N-terminal pro B-type natriuretic peptide (N-BNP) levels in cystic fibrosis patients

Pediatric Pulmonology

Volumn 42, Issue 8, 2007, Pages 699-703

  Tov, Amir Ben ^a   Paret, Gideon ^a   Sela, Ben Ami ^a   Blau, Hannah ^a   Hegesh, Julius ^a   Efrati, Ori ^a   Yahav, Yaacov ^a   Augarten, Arie ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cystic fibrosis; Lung function; N BNP; Natriuretic peptides; Pulmonary hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; POLYCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; LUNG FUNCTION TEST; MALE; NUTRITIONAL STATUS; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOASSAY; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 34547778886     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20635     Document Type: Article

References (18)

1. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
2. Sudoh T, Kangawa K, Minamino N, Matuso H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
3. Luchner A, Stevens TL, Borgeson DD. et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 1998;264:1684-1689.
4. Vanderheyden M, Bartunek J, Goethals M. Brain and other natriuretic peptides: Molecular aspects. Eur J Heart Fail 2004;6:261-268.
5. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, Gordon G, Bagg W, Oxenham H, Yandle T, Richards M, Sharpe N. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: A randomized, controlled trial. J Am Coll Cardiol 2003;42:1793-1800.
6. Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M. Serum N-terminal brain natriuretic Peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-1321.
7. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735.
8. Soldin SJ, Soldin OP, Boyajian AJ, Taskier MS. Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals. Clin Chim Acta 2006;366:304-308.
9. Gerbes AL, Dagnino L, Nguyen T, Nemer M. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab 1994;78:1307-1311.
10. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestiveheart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-209.
11. Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004;170:360-365.
12. Maisel AS, Krishnaswamy P, Nowak RM. McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167.
13. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004;25:341-346.
14. Yap LB, Mukerjee D, Timms PM, Ashrafian H, Coghlan JG. Natriuretic peptides, respiratory disease, and the right heart. Chest 2004;126:1330-1336.
15. Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide: Reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr 2004;93:603-637.
16. Wang TJ, Larson MG, Levy D, Beniamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-663.
17. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003;89:875-878.
18. Cowley CG, Bradley JD, Shaddy RE, B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004;25:336-340.